FDA批准首个生物仿制药Zarxio(诺华公司)用于化疗后升白细胞的药物
来源:
闽姑
于
2015-03-06 18:53:56
[档案] [博客] [旧帖]
[给我悄悄话]
本文已被阅读:
次
(2220 bytes)
FDA批准诺华旗下山多士(Sandoz)公司生产的首个生物仿制药Zarxio(廉价版,欧洲商品名:Zarzio,was approved in Europe in 2009 as Zarzio)上市。用于治疗原研药Neupogen(Amgen,安进公司)批准的所有五个适应症。
http://mobile.nytimes.com/2015/03/07/health/fda-approves-zarxio-first-biosimilar-drug.html?referrer=
Biosimilar drugs, which could replace some costly remedies, being made at a Novartis plant.
![](http://static01.nyt.com/images/2015/01/08/business/08FDA/08FDA-superJumbo.jpg)
A lower-cost version of the Amgen biologic drug Neupogen, used in cancer treatment,
could open the door to more such biosimilar medicines.
您的位置:
文学城 »
论坛 »
健康养生 »
FDA批准首个生物仿制药Zarxio(诺华公司)用于化疗后升白细胞的药物